SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-042724
Filing Date
2024-10-11
Accepted
2024-10-11 16:00:30
Documents
15
Period of Report
2024-10-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20241008.htm   iXBRL 8-K 27469
2 EX-16.1 ex161letterfrommarcumllp.htm EX-16.1 1447
6 GRAPHIC ex161letterfrommarcumllp001.jpg GRAPHIC 69999
  Complete submission text file 0001628280-24-042724.txt   249339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20241008.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20241008_lab.xml EX-101.LAB 21689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20241008_pre.xml EX-101.PRE 12519
17 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20241008_htm.xml XML 2733
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 241367522
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)